Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.095 USD | -3.80% | -3.85% | -17.39% |
2023 | Earnings Flash (FZMD) FUSE MEDIAL Reports Q2 Revenue $5M | MT |
2023 | Fuse Medical, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 | CI |
Sales 2021 | 20.41M 27.92M | Sales 2022 | 18.64M 25.5M | Capitalization | 10.55M 14.43M |
---|---|---|---|---|---|
Net income 2021 | -1M -1.37M | Net income 2022 | 3M 4.1M | EV / Sales 2021 | 1.59 x |
Net Debt 2021 | 2.23M 3.05M | Net Debt 2022 | 2.2M 3.01M | EV / Sales 2022 | 0.68 x |
P/E ratio 2021 |
-19
x | P/E ratio 2022 |
3.75
x | Employees | - |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 13.11% |
1 day | -3.80% | ||
1 week | -3.85% | ||
Current month | -20.83% | ||
1 month | -20.83% | ||
3 months | +5.32% | ||
6 months | -36.67% | ||
Current year | -17.39% |
Managers | Title | Age | Since |
---|---|---|---|
Christopher Reeg
CEO | Chief Executive Officer | 60 | 16-12-18 |
Mark Brooks
CHM | Chairman | 58 | 16-12-18 |
Lawrence Yellin
DFI | Director of Finance/CFO | 66 | 22-04-03 |
Members of the board | Title | Age | Since |
---|---|---|---|
Lawrence Yellin
DFI | Director of Finance/CFO | 66 | 22-04-03 |
Christopher Reeg
CEO | Chief Executive Officer | 60 | 16-12-18 |
Mark Brooks
CHM | Chairman | 58 | 16-12-18 |
1st Jan change | Capi. | |
---|---|---|
-17.39% | 6.68M | |
-4.02% | 184B | |
-1.81% | 107B | |
-1.80% | 67.52B | |
+1.83% | 50.06B | |
+9.60% | 45.67B | |
+3.40% | 41B | |
+3.03% | 26.73B | |
+4.18% | 26.47B | |
+15.23% | 25.05B |
- Stock Market
- Equities
- FZMD Stock